Accelerated Approval pathway for our ST-920 gene therapy product candidate for the treatment of Fabry disease.

Presentation

Multimerization of Chimeric Antigen Receptor (CAR) binding domains: A solution to assess tissue specificity of low to medium affinity scFv

Download PDF